MiRNAs and LincRNAs: Could They Be Considered as Biomarkers in Colorectal Cancer?

Yazar: Zarate, Ruth, Boni, Valentina, Bandres, Eva, Garcia-Foncillas, Jesús
Baskı/Yayın Bilgisi 2012

Increased vulnerability of clinical research units during the COVID‐19 crisis and their protection

Yazar: de Miguel, Maria, Doger, Bernard, Boni, Valentina, Hernández‐Guerrero, Tatiana, Moreno, Irene, Morillo, Daniel, Moreno, Victor, Calvo, Emiliano
Yayımlandı Cancer (2020)

Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array

Yazar: Abajo, Ana, Bitarte, Nerea, Zarate, Ruth, Boni, Valentina, Lopez, Ines, Gonzalez-Huarriz, Marisol, Rodriguez, Javier, Bandres, Eva, Garcia-Foncillas, Jesus
Baskı/Yayın Bilgisi 2012

Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer

Yazar: López-Vega, José Manuel, Álvarez, Isabel, Antón, Antonio, Illarramendi, José Juan, Llombart, Antonio, Boni, Valentina, García-Velloso, María José, Martí-Climent, Josep María, Pina, Luis, García-Foncillas, Jesús
Yayımlandı Cancers (Basel) (2021)

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

Yazar: Garcia-Carbonero, Rocio, Salazar, Ramon, Duran, Ignacio, Osman-Garcia, Ignacio, Paz-Ares, Luis, Bozada, Juan M., Boni, Valentina, Blanc, Christine, Seymour, Len, Beadle, John, Alvis, Simon, Champion, Brian, Calvo, Emiliano, Fisher, Kerry
Yayımlandı J Immunother Cancer (2017)

CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study

Yazar: Sanborn, Rachel E, Hamid, Omid, de Vries, Elisabeth GE, Ott, Patrick A, Garcia-Corbacho, Javier, Boni, Valentina, Bendell, Johanna, Autio, Karen A, Cho, Daniel C, Plummer, Ruth, Stroh, Mark, Lu, Lawrence, Thistlethwaite, Fiona
Yayımlandı J Immunother Cancer (2021)

Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure–response analysis

Yazar: Fudio, Salvador, Tabernero, Josep, Subbiah, Vivek, Chawla, Sant P., Moreno, Victor, Longo, Federico, Lopez, Rafael, Anton, Antonio, Trigo, Jose Manuel, Shapiro, Geoffrey, Jeong, Woondong, Villalobos, Victor Manuel, Lubomirov, Rubin, Fernandez-Teruel, Carlos, Alfaro, Vicente, Boni, Valentina
Yayımlandı Cancer Chemother Pharmacol (2020)

EPCT-08. ACTIVITY OF LAROTRECTINIB IN PEDIATRIC TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

Yazar: Goto, Hiroaki, Geoerger, Birgit, DuBois, Steven G, Grilley-Olson, Juneko E, van Tilburg, Cornelis M, Schulte, Johannes, Kang, Hyoung Jin, Tahara, Makoto, Boni, Valentina, Perreault, Sebastien, Capra, Michael, Reeves, John A, Brega, Nicoletta, Childs, Barrett H, Laetsch, Theodore W, Ziegler, David S, Doz, François
Yayımlandı Neuro Oncol (2020)

RARE-45. ACTIVITY OF LAROTRECTINIB IN TRK FUSION CANCER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMORS

Yazar: Doz, Francois, Geoerger, Birgit, DuBois, Steven G, Grilley-Olson, Juneko E, van Tilburg, Cornelis M, Italiano, Antoine, Lissat, Andrej, Jin Kang, Hyoung, Tahara, Makoto, Boni, Valentina, Perreault, Sebastien, Capra, Michael, Nanda, Shivani, Brega, Nicoletta, Holynskyj, Ariadna, Ziegler, David S, Hong, David S, Hyman, David M, Drilon, Alexander
Yayımlandı Neuro Oncol (2019)

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

Yazar: Naumann, R. Wendel, Hollebecque, Antoine, Meyer, Tim, Devlin, Michael-John, Oaknin, Ana, Kerger, Joseph, López-Picazo, Jose M., Machiels, Jean-Pascal, Delord, Jean-Pierre, Evans, Thomas R.J., Boni, Valentina, Calvo, Emiliano, Topalian, Suzanne L., Chen, Tian, Soumaoro, Ibrahima, Li, Bin, Gu, Junchen, Zwirtes, Ricardo, Moore, Kathleen N.
Yayımlandı J Clin Oncol (2019)

CX-072 (pacmilimab), a Probody(®) PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study

Yazar: Naing, Aung, Thistlethwaite, Fiona, De Vries, Elisabeth G.E., Eskens, Ferry A.L.M., Uboha, Nataliya, Ott, Patrick A., LoRusso, Patricia, Garcia-Corbacho, Javier, Boni, Valentina, Bendell, Johanna, Autio, Karen A., Randhawa, Manreet, Durm, Greg, Gil-Martin, Marta, Stroh, Mark, Hannah, Alison L., Arkenau, Hendrik-Tobias, Spira, Alexander
Yayımlandı J Immunother Cancer (2021)

CTNI-67. EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN EXPANDED DATASET

Yazar: Perreault, Sébastien, Doz, François, Drilon, Alexander, Geoerger, Birgit, Boni, Valentina, Chisholm, Julia, Dubois, Steven G, Grilley-Olson, Juneko E, Hong, David S, Italiano, Antoine, Kang, HyoungJin, Nysom, Karsten, Øra, Ingrid, Owens, Cormac, Schulte, Johannes H, Tahara, Makoto, Ziegler, David, Ellezam, Benjamin, Reeves, John A, Fellous, Marc, De La Cuesta, Esther, Laetsch, Theodore W, van Tilburg, Cornelis M
Yayımlandı Neuro Oncol (2020)

RARE-07. EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

Yazar: Perreault, Sébastien, Doz, François, Geoerger, Birgit, Nysom, Karsten, Øra, Ingrid, Boni, Valentina, Chisholm, Julia, DuBois, Steven G, Gerber, Nicolas U, Goto, Hiroaki, Grilley-Olson, Juneko E, Hansford, Jordan R, Kang, Hyoung Jin, Capra, Michael, Schulte, Johannes H, Stefanowicz, Joanna, Tahara, Makoto, Ziegler, David S, Norenberg, Ricarda, Dima, Laura, De La Cuesta, Esther, Laetsch, Theodore W, van Tilburg, Cornelis M
Yayımlandı Neuro Oncol (2021)

Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations

Yazar: Ho, Alan L., Brana, Irene, Haddad, Robert, Bauman, Jessica, Bible, Keith, Oosting, Sjoukje, Wong, Deborah J., Ahn, Myung-Ju, Boni, Valentina, Even, Caroline, Fayette, Jerome, Flor, Maria José, Harrington, Kevin, Hong, David S., Kim, Sung-Bae, Licitra, Lisa, Nixon, Ioanna, Saba, Nabil F., Hackenberg, Stephan, Specenier, Pol, Worden, Francis, Balsara, Binaifer, Leoni, Mollie, Martell, Bridget, Scholz, Catherine, Gualberto, Antonio
Yayımlandı J Clin Oncol (2021)

Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)

Yazar: Cocco, Emiliano, Carmona, F. Javier, Razavi, Pedram, Won, Helen H., Cai, Yanyan, Rossi, Valentina, Chan, Carmen, Cownie, James, Soong, Joanne, Toska, Eneda, Shifman, Sophie G, Sarotto, Ivana, Savas, Peter, Wick, Michael J., Papadopoulos, Kyriakos P., Moriarty, Alyssa, Cutler, Richard E., Avogadri-Connors, Francesca, Lalani, Alshad S., Bryce, Richard P., Chandarlapaty, Sarat, Hyman, David M., Solit, David B., Boni, Valentina, Loi, Sherene, Baselga, José, Berger, Michael F., Montemurro, Filippo, Scaltriti, Maurizio
Yayımlandı Sci Signal (2018)

Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib

Yazar: Cebrián, Arancha, Gómez del Pulgar, Teresa, Méndez-Vidal, María José, Gonzálvez, María Luisa, Lainez, Nuria, Castellano, Daniel, García-Carbonero, Iciar, Esteban, Emilio, Sáez, Maria Isabel, Villatoro, Rosa, Suárez, Cristina, Carrato, Alfredo, Munárriz-Ferrándiz, Javier, Basterrechea, Laura, García-Alonso, Mirta, González-Larriba, José Luis, Perez-Valderrama, Begoña, Cruz-Jurado, Josefina, González del Alba, Aránzazu, Moreno, Fernando, Reynés, Gaspar, Rodríguez-Remírez, María, Boni, Valentina, Mahillo-Fernández, Ignacio, Martin, Yolanda, Viqueira, Andrea, García-Foncillas, Jesús
Yayımlandı Sci Rep (2017)

HER kinase inhibition in patients with HER2- and HER3-mutant cancers

Yazar: Hyman, David M., Piha-Paul, Sarina A., Won, Helen, Rodon, Jordi, Saura, Cristina, Shapiro, Geoffrey I., Juric, Dejan, Quinn, David I., Moreno, Victor, Doger, Bernard, Mayer, Ingrid A., Boni, Valentina, Calvo, Emiliano, Loi, Sherene, Lockhart, Albert C., Erinjeri, Joseph P., Scaltriti, Maurizio, Ulaner, Gary A., Patel, Juber, Tang, Jiabin, Beer, Hannah, Selcuklu, S. Duygu, Hanrahan, Aphrothiti J., Bouvier, Nancy, Melcer, Myra, Murali, Rajmohan, Schram, Alison M., Smyth, Lillian M., Jhaveri, Komal, Li, Bob T., Drilon, Alexander, Harding, James J., Iyer, Gopa, Taylor, Barry S., Berger, Michael F., Cutler, Richard E., Xu, Feng, Butturini, Anna, Eli, Lisa D., Mann, Grace, Farrell, Cynthia, Lalani, Alshad S., Bryce, Richard P., Arteaga, Carlos L., Meric-Bernstam, Funda, Baselga, José, Solit, David B.
Yayımlandı Nature (2018)

Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer

Yazar: Smyth, Lillian M., Piha-Paul, Sarina A., Won, Helen, Schram, Alison M., Saura, Cristina, Loi, Sherene, Lu, Janice, Shapiro, Geoffrey I., Juric, Dejan, Mayer, Ingrid A., Arteaga, Carlos L., de la Fuente, Macarena I., Brufksy, Adam M., Spanggaard, Iben, Mau-Sørensen, Morten, Arnedos, Monica, Moreno, Victor, Boni, Valentina, Sohn, Joohyuk, Schwartzberg, Lee S., Gonzàlez-Farré, Xavier, Cervantes, Andrés, Bidard, François-Clement, Gorelick, Alexander N., Lanman, Richard B., Nagy, Rebecca J., Ulaner, Gary A., Chandarlapaty, Sarat, Jhaveri, Komal, Gavrila, Elena I., Zimel, Catherine, Selcuklu, S. Duygu, Melcer, Myra, Samoila, Aliaksandra, Cai, Yanyan, Scaltriti, Maurizio, Mann, Grace, Xu, Feng, Eli, Lisa D., Dujka, Melanie, Lalani, Alshad S., Bryce, Richard, Baselga, José, Taylor, Barry S., Solit, David B., Meric-Bernstam, Funda, Hyman, David M.
Yayımlandı Cancer Discov (2019)